Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack

Phase 1WithdrawnNCT00363753

University of California, San Diego

Overview

Pilot study of continuing aspirin versus switching to clopidogrel after stroke or transient ischemic attack.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Conditions

Transient Ischemic Attack Stroke Aspirin Clopidogrel

Interventions

aspirin versus clopidogrelDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age 18 and older. * Stroke or transient ischemic attack (TIA) while taking aspirin within one week of consent. * Women of child-bearing potential will be included only if there is a negative pregnancy test and they agree to birth control during the treatment period. Exclusion Criteria: * Any medical indication for a specific antiplatelet agent (aspirin, clopidogrel, ticlopidine, aggrenox), or an indication for a combination of antiplatelet agents. * Any medical indication for anticoagulation, except subcutaneous heparin for deep vein thrombosis prophylaxis. * Allergy to aspirin or clopidogrel.

Locations (2)

UCSD Hillcrest

San Diego, California, United States

UCSD

San Diego, California, United States

Outcomes

Primary Outcomes

mRS at three months.

Secondary Outcomes

Incidence of stroke at three months, bleeding events.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.